Legal Representation
Attorney
Michael J. Hertz
USPTO Deadlines
Next Deadline
708 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-06-29)
Due Date
June 29, 2027
Grace Period Ends
December 29, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 1, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 18, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 18, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 18, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 29, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 13, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 13, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 24, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 6, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 5, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 5, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 5, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 5, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 5, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 26, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 17, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 16, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 5, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
First Use Anywhere:
20190500
First Use in Commerce:
20190500
Additional Information
Design Mark
The mark consists of a drawing of an Alphyn with the words "Alphyn Biologics" beneath the drawing and in a stylized font. A horizontal line is between the words "Alphyn" and "Biologics".
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOLOGICS"